An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
CYTO365 and Eastman collaborated to create RondelO, a new turn valve for safer multi-drug administration in infusion therapy. RondelO prevents unintentional drug mixing by using Eastman Tritan copolyester, a durable and lipid-resistant material. The valve can connect six drugs sequentially, ensuring accurate drug delivery and reducing patient risk. Eastman's technical support team worked closely with CYTO365 to develop the device, which became commercially available in 2023. The innovative design includes visual and haptic cues for easy drug identification, making it a trusted tool for medical professionals.
CYTO365 ed Eastman hanno collaborato per creare RondelO, una nuova valvola a rotazione per una somministrazione più sicura di farmaci multipli nella terapia infusionale. RondelO impedisce la miscelazione involontaria dei farmaci utilizzando il copoliestere Tritan di Eastman, un materiale resistente e a prova di lipidi. La valvola permette la connessione sequenziale di sei farmaci, garantendo una somministrazione accurata dei farmaci e riducendo il rischio per il paziente. Il team di supporto tecnico di Eastman ha lavorato a stretto contatto con CYTO365 per sviluppare il dispositivo, che è diventato disponibile sul mercato nel 2023. Il design innovativo include segnali visivi e tattili per l'identificazione facile dei farmaci, rendendolo uno strumento affidabile per i professionisti medici.
CYTO365 y Eastman colaboraron para crear RondelO, una nueva válvula giratoria para la administración de múltiples fármacos más segura en terapia de infusión. RondelO evita la mezcla involuntaria de medicamentos mediante el uso de copoliéster Tritan de Eastman, un material duradero y resistente a lípidos. La válvula puede conectar seis medicamentos de manera secuencial, asegurando una entrega precisa de los fármacos y reduciendo el riesgo para el paciente. El equipo de soporte técnico de Eastman trabajó estrechamente con CYTO365 para desarrollar el dispositivo, que se comercializó en 2023. Su diseño innovador incluye indicaciones visuales y táctiles para facilitar la identificación de los medicamentos, convirtiéndolo en una herramienta de confianza para los profesionales médicos.
CYTO365와 이스트만이 협력하여 주입 요법에서 더 안전한 다중 약물 투여를 위한 새로운 회전 밸브 RondelO를 개발했습니다. RondelO는 내구성이 강하고 지방에 강한 이스트만의 트라이탄 공중 합체를 사용하여 우발적인 약물 혼합을 방지합니다. 이 밸브는 여섯 가지 약물을 차례로 연결할 수 있어 약물 전달을 정확하게 하며 환자의 위험을 줄입니다. 이스트만의 기술 지원 팀은 CYTO365와 긴밀히 협력하여 2023년에 상용화된 이 기기를 개발했습니다. 혁신적인 디자인은 약물 식별을 쉽게 할 수 있는 시각적 및 촉각적 신호를 포함하여 의료 전문가들에게 신뢰할 수 있는 도구가 되었습니다.
CYTO365 et Eastman ont collaboré pour créer RondelO, une nouvelle vanne tournante pour une administration plus sûre de médicaments multiples en thérapie par perfusion. RondelO empêche le mélange involontaire de médicaments en utilisant le copolyester Tritan d'Eastman, un matériel durable et résistant aux lipides. La valve peut connecter six médicaments de manière séquentielle, assurant une livraison précise des médicaments et réduisant les risques pour le patient. L'équipe de support technique d'Eastman a travaillé étroitement avec CYTO365 pour développer l'appareil, qui est devenu disponible commercialement en 2023. Le design innovant comprend des indices visuels et haptiques pour une identification facile des médicaments, ce qui en fait un outil de confiance pour les professionnels médicaux.
CYTO365 und Eastman haben zusammengearbeitet, um RondelO, ein neues Drehventil für eine sicherere Verabreichung von Mehrfachmedikamenten in der Infusionstherapie, zu entwickeln. RondelO verhindert unbeabsichtigtes Vermischen von Medikamenten durch die Verwendung von Eastman Tritan Copolyester, einem haltbaren und lipidresistenten Material. Das Ventil kann sechs Medikamente nacheinander verbinden, was eine genaue Medikamentenabgabe sicherstellt und das Patientenrisiko verringert. Eastmans technisches Support-Team arbeitete eng mit CYTO365 zusammen, um das Gerät zu entwickeln, das 2023 kommerziell verfügbar wurde. Das innovative Design umfasst visuelle und haptische Hinweise zur einfachen Identifizierung von Medikamenten, was es zu einem vertrauenswürdigen Werkzeug für medizinisches Fachpersonal macht.
Positive
CYTO365 and Eastman partnered to develop RondelO, a turn valve for safer multi-drug administration in infusion therapy.
RondelO prevents unintentional drug mixing by using Eastman Tritan copolyester, a lipid-resistant material.
The valve can connect six drugs sequentially, enhancing accuracy in drug delivery and reducing patient risk.
Eastman's technical support team collaborated with CYTO365 to create the device, which was launched commercially in 2023.
The design features visual and haptic indicators for easy drug identification, making it a reliable tool for medical professionals.
Negative
None.
RondelO™ is a new turn valve for safer multi-drug administration.
NORTHAMPTON, MA / ACCESSWIRE / April 24, 2024 / Eastman Eastman
Swedish medical technology company CYTO365 and Eastman worked together to create a new medical component for infusion therapy that lowers patient risk.
CYTO365's founder and CEO Micael Törnblom noticed that, with current infusion treatment, medical professionals could unintentionally mix incompatible drugs during infusion therapy. To help prevent that, the company developed RondelO™, a turn valve with multiple inlets that stops unintentional mixing. It can connect six drugs, which are given one at a time with flushing fluids in between.
This turn valve is considered revolutionary because it supports back-to-back drug infusion through the same device. But the CYTO365 team knew it would need durable, safe material that supports accurate molding and is crystal clear.
The CYTO365 team met Eastman business development manager Theo Wuebbels in 2019 at a medical technology trade fair. Having liked what they saw and heard, CYTO365 leaders turned to him and Eastman for help. Eastman's technical support team incorporated Eastman Tritan™ copolyester, which helped create an accurate mold without cracks.
"We want to support medical professionals through safe and reliable medical equipment," Törnblom said. "But to help them, the material must be lipid-resistant and crack-free to oncology drugs, so we needed a copolyester and innovation partner we could trust. That's why we chose Eastman."
Eastman performed simulation testing for material degradation and mold filling with Tritan. The technical support team worked with CYTO365 to identify a mold-drying process.
"One of Eastman's greatest strengths is our hands-on, collaborative approach to personalized solutions," Wuebbels said. "Our technical support team worked directly with CYTO365. We were involved from an early phase of product development to align on design, material selection and tool development. We evaluated their exact needs and even shortened their time to market with a device that was safe and durable."
RondelO became commercially available to IV manufacturers in 2023. The design includes a visual and haptic "click" position for each drug for easy identification. It is available in two-, four- and six-port options.
"Tritan really lives up to both our expectations and our customers' expectations," Törnblom said. "RondelO can be the physical barrier we intended for infusion therapy, and Tritan has helped us make it a trusted device for medical professionals. The precision this copolyester brings to our device is truly innovative and revolutionary."
